FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

A simulation model has shown a hybrid colorectal cancer screening process to be clinically and cost effective, according to The Oncology Report. The method includes an annual fecal immunological test ...

Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

COLUMBUS, Ohio – A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study published in JAMA Network ...

A newly published study revealed an at-home colon cancer screening test reduces risk of colorectal cancer death by 33%, according to a new study published in JAMA Network Open. Researchers at the Ohio ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

When it comes to colorectal cancer, there are several tests used for screening which one to choose depends on the patient. The best test is the one that gets done and done. Well, Dr Cke Dalba with the ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Ulcerative colitis patients who discontinued 5-aminosalicylic acid (5-ASA) monotherapy have an increased risk of relapse, ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...